Source: Global Legal Chronicle

Pharmapacks: The Carlyle Group's $250 Million Strategic Investment in Pharmapacks

Cooley LLP advised Pharmapacks on the deal. Pharmapacks obtained a more than $250 million strategic investment from The Carlyle Group. The growth investment values the ecommerce [...]

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
500-1.0K
Andrew Vagenas's photo - CEO of Pharmapacks

CEO

Andrew Vagenas

CEO Approval Rating

89/100

Read more